To print: Select File and then Print from your browser's menu

Title: Conductive Keratoplasty is a Safe and Effective Treatment for Presbyopia: Presented at AAO

"Conductive Keratoplasty is a Safe and Effective Treatment for Presbyopia: Presented at AAO"

By Deanna M Green, PhD ANAHEIM, CA -- November 20, 2003 -- Conductive keratoplasty (CK) safely and effectively improves near and distance vision at 1 year in patients with presbyopia, according to findings presented here November 16th at the American Academy of Ophthalmology's 2003 Annual Meeting. CK is a non-ablative, collagen shrinking procedure that uses radiofrequency energy to change corneal curvature. CK was approved by the U.S. Food and Drug Administration (FDA) in April 2002 for the treatment of low to moderate hyperopia. Whether CK is also an effective treatment for patients with presbyopia is still under investigation. Daniel S. Durrie, MD, at the Hunkeler Eye Center, Kansas City, Missouri, United States, and colleagues conducted a U.S. FDA clinical trial to evaluate the safety and efficacy of CK in the treatment of presbyopia. The study included 150 patients (mean age, 53) who sought treatment for presbyopia between +0.75D and +3.00D and 2 lines of BSCVA or induced cylinder." [Study title: USFDA Presbyopic Clinical Trial Results of Conductive Keratoplasty for Near Vision Restoration. Abstract PO101]

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.